LP
YARW

LMR Partners’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

LMR Partners’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22
Closed -$27K – 1288
2021
Q3 		$27K Hold
22
– – ﹤0.01% 971
2021
Q2 		$69K Buy
+22
New +$87.1K ﹤0.01% 936

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

LMR Partners's YARW Position: Q4 2021 in Review

LMR Partners sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q4 2021, closing a stake of 22 shares — an estimated $27K sold.

LMR Partners first reported a position in YARW in Q2 2021 and held it in 2 quarters. The position peaked at $69K in Q2 2021. 49 funds tracked by Wall St. Rank hold YARW as of Q4 2021.

  • LMR Partners reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • LMR Partners sold 22 Yarrow Bioscience, Inc. Common Stock shares in Q4 2021, an estimated $27K.
  • LMR Partners first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • LMR Partners's Yarrow Bioscience, Inc. Common Stock position peaked at $69K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q4 2021.

Based on LMR Partners's 13F filing for Q4 2021, filed 14 Feb 2022.